01953nam 2200565 a 450 991046569130332120200520144314.01-61668-478-X(CKB)2560000000068770(EBL)3019875(SSID)ssj0000415799(PQKBManifestationID)12173982(PQKBTitleCode)TC0000415799(PQKBWorkID)10416286(PQKB)11606005(MiAaPQ)EBC3019875(Au-PeEL)EBL3019875(CaPaEBR)ebr10674883(OCoLC)923662021(EXLCZ)99256000000006877020100122d2010 uy 0engur|n|---|||||txtccrDevelopment of new MDR-tuberculosis drugs[electronic resource] /Jarmila Vinšová and Martin KrátkýNew York Nova Science Publishers/Nova Biomedicalc20101 online resource (112 p.)Pharmacology-research, safety testing and regulationDescription based upon print version of record.1-61668-233-7 Includes bibliographical references and index.Resistance to commonly used drugs, mechanism of the action -- Research of novel MDR potential drugs.Pharmacology-research, safety testing, and regulation series.Antitubercular agentsMultidrug-resistant tuberculosisChemotherapyElectronic books.Antitubercular agents.Multidrug-resistant tuberculosisChemotherapy.615.5/8Vinšová Jarmila986993Krátký Martin1960-986994MiAaPQMiAaPQMiAaPQBOOK9910465691303321Development of new MDR-tuberculosis drugs2255520UNINA